Neuronatin Promotes the Progression of Non-small Cell Lung Cancer by Activating the NF-κB Signaling

Title:Neuronatin Promotes the Progression of Non-small Cell Lung Cancer by Activating the NF-κB Signaling

Volume: 24 Issue: 11

Author(s): Huanwen Xiong, Guohua Chen, Ke Fang, Weiguo Gu and Feng Qiu*

Affiliation:

• Department of Oncology, Gaoxin Branch of The First Affiliated Hospital of Nanchang University, Nanchang, P.R. China

Abstract:

Background and Objectives: Understanding the regulatory mechanisms involving neuronatin (NNAT) in non-small cell lung cancer (NSCLC) is an ongoing challenge. This study aimed to elucidate the impact of NNAT knockdown on NSCLC by employing both in vitro and in vivo approaches.

Methods: To investigate the role of NNAT, its expression was silenced in NSCLC cell lines A549 and H226. Subsequently, various parameters, including cell proliferation, invasion, migration, and apoptosis, were assessed. Additionally, cell-derived xenograft models were established to evaluate the effect of NNAT knockdown on tumor growth. The expression of key molecules, including cyclin D1, B-cell leukemia/lymphoma 2 (Bcl-2), p65, matrix metalloproteinase (MMP) 2, and nerve growth factor (NGF) were examined both in vitro and in vivo. Nerve fiber density within tumor tissues was analyzed using silver staining.

Results: Upon NNAT knockdown, a remarkable reduction in NSCLC cell proliferation, invasion, and migration was observed, accompanied by elevated levels of apoptosis. Furthermore, the expression of cyclin D1, Bcl-2, MMP2, and phosphorylated p65 (p-p65) showed significant downregulation. In vivo, NNAT knockdown led to substantial inhibition of tumor growth and a concurrent decrease in cyclinD1, Bcl-2, MMP2, and p-p65 expression within tumor tissues. Importantly, NNAT knockdown also led to a decrease in nerve fiber density and downregulation of NGF expression within the xenograft tumor tissues.

Conclusion: Collectively, these findings suggest that neuronatin plays a pivotal role in driving NSCLC progression, potentially through the activation of the nuclear factor-kappa B signaling cascade. Additionally, neuronatin may contribute to the modulation of tumor microenvironment innervation in NSCLC. Targeting neuronatin inhibition emerges as a promising strategy for potential anti-NSCLC therapeutic intervention.

Cite this article as:

Xiong Huanwen, Chen Guohua, Fang Ke, Gu Weiguo and Qiu Feng*, Neuronatin Promotes the Progression of Non-small Cell Lung Cancer by Activating the NF-κB Signaling, Current Cancer Drug Targets 2024; 24 (11) . https://dx.doi.org/10.2174/0115680096271746240103063325